B2B marketplace for global health
Hospitals, ministries and clinics in low- and middle-income countries buy medicines and health products from suppliers worldwide, with the price, the financing and the delivery in one place.
Underneath, a live network of every product, price, supplier and market.
A social impact health-tech venture. We cap our markup at 10% and redeploy a percentage of profits into the health systems we serve.
Backed by
Working with
Mission and vision
The vision
The mission
Axmed builds the marketplace, financing and logistics that make it worth a supplier's while to serve low- and middle-income countries, so the medicines and health products people need actually arrive.
Every price, spread and fee is visible to both sides of the trade. We cap our own markup at 10%.
Access that depends on donations ends when the donation ends. We build terms that hold on their own.
Patients reached, savings delivered and tons shipped are published every year, including what went wrong.
The asymmetry
Over four fifths of the world's population lives in low- and middle-income countries. Those same countries account for less than a twentieth of global pharmaceutical revenue. Hundreds of millions of people go without the medicines and health products they need.
The demand is there. A district hospital orders on its own. So does the ministry, and so does the NGO down the road. Each order is too small for a manufacturer to serve well, so buyers pay more and wait longer, working with outdated systems and thin financing, while suppliers carry the cost and the risk of serving these markets one contract at a time.
This is a market failure, and market failures can be engineered out. That is the job of the marketplace, the financing and the logistics.
See how it worksHow it works
One order, four steps. The marketplace pools what many buyers need into orders suppliers compete for, then finances and delivers them.
A hospital, ministry or NGO lists the products it needs, alongside every other buyer on the platform.
Vetted manufacturers and distributors see the pooled demand and quote against each other. Prices come down because the order is worth winning.
Longer payment terms, and RIFF financing for buyers who need it, are built into the order instead of negotiated afterwards.
Shipments are tracked from dispatch to delivery through global logistics partners, with the compliance paperwork handled along the way.
Solutions
Three products. Each works on its own, and together they carry an order from a factory to a clinic.
Procurement
Where hospitals, ministries and NGOs buy medicines and health products from suppliers worldwide, at a price they can see, with the financing and delivery already arranged.
Movement
The software that moves an order from a factory to a clinic. Every shipment tracked, every party working from the same record, the compliance paperwork handled.
Market access
Experienced guidance for manufacturers, procurers and funders entering markets where the rules, the risks and the routes to patients are different.
Two sides, one market
One marketplace, two very different jobs. Start from yours.
Ministries, hospitals, NGOs, faith-based networks and mission-driven private providers.
You need the products, at a price your budget survives.
Manufacturers and distributors, local to global.
You want the volume, without the cost of chasing it.
Integrated financing
Many buyers know exactly what they need and cannot pay for it upfront. So the capital sits inside the marketplace, arranged with development institutions and financial partners, rather than being something a hospital has to find on its own.
Working capital for buyers who would otherwise wait for a grant or go without. A hospital or NGO draws on the facility to stock what it needs, repays as it is paid, and the facility revolves to the next order.
Funded by the Gates Foundation. For every dollar a buyer spends on maternal, newborn and child health products through the marketplace, the fund adds another. The buyer chooses what to order.
Impact
Every number here appears in the yearly impact report, with how it was counted and what did not work.
Voices
Procurers, distributors and research institutes who have run real volume through the platform.
Through our partnership with Axmed, we have a greater impact on improving maternal and child health outcomes and ending preventable deaths in some of Africa's most under-resourced communities.
Axmed has proven that a strong model, backed by operational excellence and deep commitment, can deliver real impact even within complex environments. They have consistently demonstrated an exceptional ability to navigate the complexities of the global healthcare supply chain, developing pragmatic strategies that produce measurable and sustainable impact.
At GMRI, we engaged Axmed Global Health Advisory to work with us on the go-to-market / access strategy. Their professionalism, experience, working relationships with our teams and knowledge have been outstanding.
Media
Announcements, and the team's writing on procurement, regulation and access.
Development financing has changed permanently. Axmed Global Health Advisory's Access360 framework builds access strategy into product development.
How Axmed turns day-long manual prequalification and GMP and GDP audit work into real-time quality intelligence with AI. By Sofia Radley-Searle, COO.
Rethinking medicine quality in East Africa's supply chain: the medicine reached the patient, the label was correct, and it did not work.
Axmed is ranked second in healthcare globally in Fast Company's Most Innovative Companies of 2026, for its technology-first approach to procurement.
A demo uses what you actually buy or sell. We will show you the prices, the financing and the route to delivery on the marketplace.